Friday, January 13, 2012 8:14:31 AM
Spoorstraat 50
Venlo, 5911 KJ
Netherlands - Map
Phone: 31 77 320 8400
Fax: 31 77 320 8409
Website: http://www1.qiagen.com
Recent QGEN News
- QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
- QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements • GlobeNewswire Inc. • 03/18/2024 08:05:00 PM
- QIAGEN announces Form 20-F annual report filing for 2023 results • GlobeNewswire Inc. • 03/11/2024 09:59:51 AM
- QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery • GlobeNewswire Inc. • 02/27/2024 10:44:59 PM
- QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 02:47:31 PM
- QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability • GlobeNewswire Inc. • 02/06/2024 09:05:00 PM
- QIAGEN announces partnership with Penn State University to advance microbiome sciences • GlobeNewswire Inc. • 01/25/2024 03:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:13:55 PM
- QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- QIAGEN N.V. to release results for Q4 2023 and hold webcast • GlobeNewswire Inc. • 01/11/2024 12:53:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 02:59:04 PM
- QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems • GlobeNewswire Inc. • 01/08/2024 07:00:00 AM
- QIAGEN announces plans to return approximately $300 million to shareholders • GlobeNewswire Inc. • 01/07/2024 06:07:00 PM
- QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business • GlobeNewswire Inc. • 01/04/2024 09:05:00 PM
- QIAGEN expands business in Middle East with new regional headquarters and major projects • GlobeNewswire Inc. • 01/03/2024 07:00:00 AM
- DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy • GlobeNewswire Inc. • 11/30/2023 09:05:00 PM
- QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation • GlobeNewswire Inc. • 11/15/2023 09:05:00 PM
- QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers • GlobeNewswire Inc. • 11/09/2023 09:05:00 PM
- QIAGEN launches complete Sample to Insight workflow for microbiome research • GlobeNewswire Inc. • 11/06/2023 09:05:00 PM
- QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System • GlobeNewswire Inc. • 11/02/2023 12:00:00 PM
- QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System • PR Newswire (US) • 11/02/2023 12:00:00 PM
- QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CER • GlobeNewswire Inc. • 10/30/2023 08:05:00 PM
- QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer • GlobeNewswire Inc. • 10/26/2023 12:00:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM